Truvestments Capital LLC Raises Stake in UnitedHealth Group Incorporated (NYSE:UNH)

Truvestments Capital LLC lifted its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 13.0% during the third quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 591 shares of the healthcare conglomerate’s stock after buying an additional 68 shares during the quarter. Truvestments Capital LLC’s holdings in UnitedHealth Group were worth $346,000 at the end of the most recent quarter.

Other institutional investors have also bought and sold shares of the company. Delta Financial Group Inc. lifted its holdings in UnitedHealth Group by 1.0% in the 3rd quarter. Delta Financial Group Inc. now owns 1,650 shares of the healthcare conglomerate’s stock worth $965,000 after purchasing an additional 17 shares in the last quarter. Signature Resources Capital Management LLC grew its stake in shares of UnitedHealth Group by 40.0% during the second quarter. Signature Resources Capital Management LLC now owns 63 shares of the healthcare conglomerate’s stock valued at $32,000 after buying an additional 18 shares during the last quarter. Saxony Capital Management LLC lifted its stake in shares of UnitedHealth Group by 3.5% during the 2nd quarter. Saxony Capital Management LLC now owns 530 shares of the healthcare conglomerate’s stock worth $270,000 after acquiring an additional 18 shares during the last quarter. GoalVest Advisory LLC grew its position in UnitedHealth Group by 0.6% in the 2nd quarter. GoalVest Advisory LLC now owns 3,124 shares of the healthcare conglomerate’s stock valued at $1,591,000 after acquiring an additional 18 shares during the last quarter. Finally, Fiduciary Group LLC lifted its position in shares of UnitedHealth Group by 0.5% during the second quarter. Fiduciary Group LLC now owns 3,695 shares of the healthcare conglomerate’s stock worth $1,882,000 after purchasing an additional 18 shares during the last quarter. Hedge funds and other institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Stock Performance

UNH opened at $605.53 on Tuesday. The firm’s 50-day moving average price is $582.96 and its 200-day moving average price is $553.99. The company has a market cap of $557.26 billion, a P/E ratio of 39.45, a price-to-earnings-growth ratio of 1.73 and a beta of 0.58. The company has a quick ratio of 0.91, a current ratio of 0.91 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a 52-week low of $436.38 and a 52-week high of $630.73.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, October 15th. The healthcare conglomerate reported $7.15 EPS for the quarter, topping the consensus estimate of $7.00 by $0.15. The business had revenue of $100.82 billion during the quarter, compared to the consensus estimate of $99.14 billion. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The business’s revenue for the quarter was up 9.2% compared to the same quarter last year. During the same period in the previous year, the firm posted $6.56 earnings per share. As a group, equities analysts anticipate that UnitedHealth Group Incorporated will post 27.6 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Tuesday, December 17th. Investors of record on Monday, December 9th will be given a $2.10 dividend. The ex-dividend date of this dividend is Monday, December 9th. This represents a $8.40 dividend on an annualized basis and a yield of 1.39%. UnitedHealth Group’s dividend payout ratio is currently 54.72%.

Analysts Set New Price Targets

A number of equities analysts have recently commented on UNH shares. Morgan Stanley reduced their target price on shares of UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating on the stock in a research report on Wednesday, October 16th. TD Cowen upped their target price on UnitedHealth Group from $601.00 to $609.00 and gave the stock a “buy” rating in a report on Friday, October 18th. Hsbc Global Res downgraded UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a report on Thursday, October 17th. KeyCorp started coverage on shares of UnitedHealth Group in a research report on Friday, October 11th. They set an “overweight” rating and a $675.00 target price on the stock. Finally, HSBC cut shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Thursday, October 17th. Four research analysts have rated the stock with a hold rating, seventeen have given a buy rating and two have issued a strong buy rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $615.53.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.